Posted in | News | Carbon Nanotubes

SouthWest NanoTechnologies CEO Named One of the Most Influencial Nanotech Leaders of 2010

SouthWest NanoTechnologies, Inc. (SWeNT), the world leader in high quality, Single-Wall and Specialty Multi-Wall (SMW) carbon nanotubes (CNT), today announced that its CEO Dave Arthur has been named as one of the most influential nanotechnology leaders of 2010 by the Nanobusiness Alliance.

The Nanobusiness Alliance is the premier nanotechnology leadership group whose members are leaders in the field and have made significant contributions in the nanotechnology community.

"Dave Arthur is a nanotechnology evangelist," explains Vince Caprio, president of the Washington DC based Nanobusiness Alliance. "He is outspoken on the need for the U.S. to have a thriving nanotechnology industry and reduce its reliance on rare earth materials that are increasingly more expensive and diminishing in availability. He is also working to develop nano applications used in lighting, energy, armor and printed electronics using specialized, nanotubes available in commercial quantities which has made SouthWest technologies a thriving business."

In addition to his position as CEO of SouthWest NanoTechnologies, Arthur is also president of Chasm Technologies, a nano R&D firm which has developed a carbon nanotube ink that can be used on conventional printing equipment.

"It is an honor to be recognized among this prestigious group of major technology firms and others as we share a similar vision for the U.S. to be a leader in nanotechnology, and are working tirelessly to advance that," Arthur states. "We continue to see great success for the industry and for SWeNT and appreciate the recognition from the Nanobusiness Alliance, the industry's strongest advocate."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.